PRESS RELEASE IDOGEN AB
Idogen AB | Aktiespararna
biotech | pharma | diagnostics | devices
Idogen's Historical Milestones - Idogen
Iodogen | C16H10Cl4N4O2 | ChemSpider
Idogen presentation - Idogen
Idogen AB (publ) Corp. Reg. No.
Idogen AB | Aktiespararna
Idogen - Crunchbase Company Profile & Funding
biotech | pharma | diagnostics | devices
Idogen AB publicerar Årsredovisning för 2018
BioInsights - Bringing advanced therapies to the clinic: the Swedish National ATMP Consortium (CAMP/SWElife ATMP)
Idogen - Engineering Immune Tolerance
niklas wallett - Idogen
Idogen AB (publ)
Idogen's Historical Milestones - Idogen
Idogen's cell technology successfully advanced to large-scale production
Noteringar i veckan
Idogen - Crunchbase Company Profile & Funding
Trading Direkt analyserar bolagen på Spotlight 2018-10-18: Plejd & Idogen - YouTube
Idogen AB Interim report Idogen AB Interim report
Nyemission: Idogen förbereder för fas I/IIa-studie Idogen är ett svenskt bioteknikbolag baserat i Lund. Bolaget utvecklar tolerogena cellterapier som gör det möjligt att undvika en oönskad aktivering av kroppens immunsystem. Cellterapin baseras
Idogen's cell technology successfully advanced to large-scale production - Idogen
Q3 ENG - Idogen
biotech | pharma | diagnostics | devices
Idogen Year end report 3 - Idogen
Idogen AB (publ) Org nr
Stories: EIC-funded company Idogen starts trading on Nasdaq First North Growth Market | EIC Community
